Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05047978 · ClinicalTrials.gov registry record · NA
Growth and Tolerance of a Partially Hydrolyzed Infant Formula
A NA study, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 244
- Enrollment target
NCT05047978 is a NA study that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 244 participants.
The verdict
NCT05047978, a NA study, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 244 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the growth and tolerance of infants who consume either an infant formula with intact proteins or an infant formula with partially hydrolyzed proteins through approximately 12 months of age.
Interventions
- OTHER Cow's milk protein infant formula
- OTHER Partially hydrolyzed protein infant formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2021-08-28 |
| Est. Completion | 2023-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05047978
The ClinicalTrials.gov registry entry for NCT05047978 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mead Johnson Nutrition, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cow's milk protein infant formula is the first listed.
NCT05047978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05047978 about?
NCT05047978 is a clinical study titled "Growth and Tolerance of a Partially Hydrolyzed Infant Formula". The purpose of this research study is to compare the growth and tolerance of infants who consume either an infant formula with intact proteins or an infant formula with partially hydrolyzed proteins through approximately 12 months of age.
What is the current status of trial NCT05047978?
This trial is currently completed. It is a NA study. The enrollment target is 244 participants. The study started on 2021-08-28. Estimated completion is 2023-11-21.
What interventions are being tested in trial NCT05047978?
The interventions under investigation include: Cow's milk protein infant formula (OTHER), Partially hydrolyzed protein infant formula (OTHER).
Who is sponsoring clinical trial NCT05047978?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.